Product Overview
Unlearn AI simulation revolutionizes clinical development by leveraging AI-generated digital twins—virtual simulations of trial participants—to optimize study design, shorten timelines, and boost statistical power.
Digital Twin Generation (DTG)
Trained on extensive patient-level historic clinical data, Unlearn’s DTGs produce personalized forecasts of how each trial participant would progress under standard care—effectively simulating a virtual control arm.
TwinRCT® Methodology
Integrates digital twin predictions into trial analysis to:
- Conduct fully randomized trials with ~33% fewer control participants, maintaining statistical rigor.
- Support single-arm designs by using simulated controls.
- This EMA-qualified approach aligns with FDA guidance.
Predictive & Adaptive Insights
Continuous simulation enables:
- Real‑time subgroup and endpoint forecasting
- Early interim decisions
- Identification of likely responders
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Advanced Model Architecture
Utilizes state-of-the-art Neural Boltzmann Machines for time-series forecasting, delivering high accuracy and robustness—even with limited baseline data.
Broad Therapeutic Coverage
Offers disease-specific DTGs for areas including neurology (Alzheimer’s, ALS, Parkinson’s), immunology, metabolic and more. Sponsors can also develop custom DTGs.
About the company
Unlearn.ai is an innovative clinical trial platform that harnesses AI-driven Digital Twin Generators—virtual replicas of trial participants—to streamline trial execution and enhance statistical power. It enables trial sponsors to reduce control arm sizes, launch faster studies, and make data-driven decisions in real time.
